Ignite Creation Date:
2024-05-06 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05202041
Status:
UNKNOWN
Last Update Posted:
2022-02-09
First Post:
2022-01-07
Brief Title:
Non-IRA Functional Evaluation With AccuFFRangio in NSTE-ACS
Sponsor:
Wuhan Asia Heart Hospital
Organization:
Wuhan Asia Heart Hospital
Study Overview
Official Title:
Diagnostic Performance and Prognostic Ability of AccuFFRangio for Non-IRA in NSTE-ACS Patients
Status:
UNKNOWN
Status Verified Date:
2022-01
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective single-center clinical trial AccuFFRangio ArteryFlow Technology Co Ltd Hangzhou China is a novel method for evaluating the functional significance of coronary stenosis by computing the pressure in the vessel based on angiographic images The purpose of this study is to investigate the diagnostic performance and prognostic ability of AccuFFRangio for non-IRA in NSTE-ACS patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None